Health Care Equipment

Medtronic

Medtronic Receives CE Mark Approval for VitalFlow Transport Frame

Medtronic Launches ENDURANCE Study Recruiting Patients for Altaviva Device Evaluation

Medtronic's Mosaic Neo Mitral Bioprosthesis Approved and Launched in the U.S.

Itron and Medtronic Suffer Cyber Attacks

Medtronic Discloses Unauthorized Access to Corporate IT Systems

Medtronic Receives FDA Breakthrough Device Designation for Sphere-9 Catheter for Ventricular Tachycardia

Medtronic Presents Findings from Heart Rhythm Management Device Studies

Medtronic Receives CE Mark for ApexCut Powered ENT Surgery Blade

Kingswood Wealth Advisors LLC Increases Holdings in Medtronic

Jinhai Medical Technology Completes Strategic Transformation and Establishes Joint Venture with Medtronic China

Medtronic Reaffirmed with Hold Rating, Target Price Set at $95.00

Medtronic Completes Acquisition of CathWorks for $585 Million

Pulnovo Medical Completes $100 Million Series D Financing and Signs Commercial Cooperation Agreement with Medtronic

FactSet Analysts Lower Medtronic's 2026 EPS Forecast to $5.52

Medtronic Integrates GE Healthcare's System to Enhance Neurosurgery Capabilities

GE Healthcare announces Digital Integration of Bkactiv Intraoperative Ultrasound System with Medtronic Stealth Axis Surgical Navigation System

Evercore downgrades Medtronic's target price to $108.00

Medtronic's OmniaSecure Defibrillation Lead Receives CE Mark and First Commercial Implant in Europe

Medtronic's AI Technology Increases Valve Intervention Rate by 40%

Medtronic Receives FDA Approval for New Stealth AXiS™ Surgical System

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Earning Release Date

财报预告

FY2026 Q4 Earning Release 2026.06.03 (EST) Pre-Market

Medtronic plc (MDT.US) Q3 2026 Earnings Conference Call

Medtronic plc (MDT.US) Q2 2026 Earnings Conference Call

Medtronic plc (MDT.US) Q4 2025 Earnings Conference Call

Medtronic plc (MDT.US) Q3 2025 Earnings Conference Call

Medtronic plc (MDT.US) Q2 2025 Earnings Conference Call

SBIO

LABU

Arbejdsmarkedets Tillaegspension acquired a new stake in Medtronic PLC, purchasing 233,477 shares valued at approximately $22.4 million. Other investors also increased their positions in Medtronic. The company reported a quarterly EPS of $1.36, exceeding estimates, with revenue of $9.02 billion. Medtronic announced a quarterly dividend of $0.71, yielding 3.7%. Analysts have mixed ratings on the stock, with an average price target of $107.80.

Market Beat

iShares US Medical Devices

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

SPDR S&P Health Equip

Intuitive Surgical

JPMorgan Chase

Jefferies Financial

CICC

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Arbejdsmarkedets Tillaegspension Makes New Investment in Medtronic PLC $MDT

Medtronic PLC (MDT) shares fell 1.07% to $76.15 amid a tough trading day, while the S&P 500 and Dow Jones also declined. Despite this, Medtronic outperformed competitors like Johnson & Johnson, Danaher Corp., and Abbott Laboratories, which saw larger losses. The stock remains 28.38% below its 52-week high of $106.33.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Danaher

Abbott Laboratories

Factset Research

Medtronic PLC Stock Outperforms Competitors Despite Losses On The Day

Gradient announces that Principal Toxicologist Lindsey Borton and Medtronic Sr. Distinguished Toxicologist Kelly Coleman have been awarded the 2026...

prnewswire

14:11 ETGradient Toxicologist Lindsey Borton Wins 2026 Lush Prize for Political Advocacy

Medtronic PLC (MDT) shares rose 3.06% to $76.82 on a mixed trading day, outperforming competitors like Johnson & Johnson and Abbott Laboratories. The stock ended a two-day losing streak but remains 27.75% below its 52-week high of $106.33. Trading volume reached 10.3 million, surpassing the 50-day average of 8.8 million. The Dow Jones Industrial Average increased by 0.11%, while the S&P 500 Index fell by 0.16%.

Medtronic PLC Stock Outperforms Competitors On Strong Trading Day

The article discusses three stocks poised to benefit from AI in healthcare: Pfizer, Tempus AI, and Medtronic. Pfizer, with a market cap of $146.4 billion, focuses on drug development and AI-supported R&D, despite facing revenue declines. Tempus AI, valued at $9 billion, leverages AI for precision medicine but struggles with profitability. Medtronic, worth $97.8 billion, combines AI with medical devices, showing strong growth potential and a 3.73% dividend yield. Each company presents unique opportunities and risks in the evolving healthcare landscape driven by AI.

- The article discusses the integration of AI in healthcare, focusing on how companies like Pfizer, Tempus AI, and Medtronic are leveraging AI for improved diagnostics and treatment.  
- Pfizer, with a market cap of US$146.4 billion, is enhancing R&D through AI while facing revenue declines and dividend pressures.  
- Tempus AI and Medtronic are also highlighted for their innovative approaches, but they face challenges such as significant losses and external funding reliance.

Medtronic(MDT.US)

Arbejdsmarkedets Tillaegspension Makes New Investment in Medtronic PLC $MDT

Medtronic PLC Stock Outperforms Competitors Despite Losses On The Day

14:11 ETGradient Toxicologist Lindsey Borton Wins 2026 Lush Prize for Political Advocacy

Medtronic PLC Stock Outperforms Competitors On Strong Trading Day

If AI Reshapes Healthcare, These Three Stocks Could Lead

Trending